|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Impairment of goodwill | |||||
| Shared-based compensation liabilities | |||||
| Impairment of assets held for sale | |||||
| Loss on sale of business | |||||
| Amortization of debt issuance costs | |||||
| Noncash lease expense | |||||
| Change in fair value of warrant liabilities | |||||
| Deferred tax benefits | |||||
| Gain on extinguishment of tax receivable agreement liability | |||||
| Gain on extinguishment of debt | |||||
| Nonrelated Party | |||||
| Related Party | |||||
| Total gain on extinguishment of debt | |||||
| Bad debt expense | |||||
| Other, net | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Deferred revenue | |||||
| Long-term earnout liabilities | |||||
| Other non-current liabilities | |||||
| Net cash used in operating activities | |||||
| Cash Flows from Investing Activities | |||||
| Purchases of property and equipment | |||||
| Purchases of intangible asset | |||||
| Capitalized software development costs | |||||
| Acquisition of businesses, net of cash acquired | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities | |||||
| Proceeds from related-party loan, net of lender fees | |||||
| Repayments of related party loan, inclusive of lender fees | |||||
| Proceeds from 2023 Revolving Note | |||||
| Repayment of 2023 Revolving Note, inclusive of lender fees | |||||
| Repayment of term loan | |||||
| Repayment of 2022 Revolving Facility | |||||
| Payments for financing costs | |||||
| Payment of acquisition holdback | |||||
| Payment of promissory note | |||||
| Proceeds from revolver facility | |||||
| Taxes paid related to net settlement of stock awards | |||||
| Distributions to members, net of contributions | |||||
| Proceeds from private placement of Class A common stock | |||||
| Repurchases of Class A common stock | |||||
| Proceeds from Warrant exercises | |||||
| Purchases of treasury stock | |||||
| Cash received from the Backstop | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes in cash, cash equivalent and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of the period | |||||
| Cash, cash equivalents and restricted cash, end of the period | |||||
| Supplemental cash flow information: | |||||
| Cash refunds for income taxes | |||||
| Cash paid for interest | |||||
| Operating lease right-of-use assets obtained in exchange for operating lease liabilities | |||||
| Tenant improvements paid by lessor | |||||
| Cash paid for operating lease liabilities | |||||
| Stock-based compensation included in capitalized software development costs | |||||
| Equity issuance to settle intercompany loan | |||||
| Settlement of incentive plan through issuance of common stock | |||||
| Restructuring of holdback liability to promissory note | |||||
| Deferred consideration for acquisition | |||||
| Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets: | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
| Cash and restricted cash included in assets held for sale from discontinued operations | |||||
Loading...